E Fund (HK) Solactive Biopharma Select Index ETF (03186.HK) Rises 0.74%, NAV at HKD 14.978
NewTimeSpace News: As of 13:53 on September 8, E Fund (HK) Solactive Biopharma Select Index ETF (03186.HK) stood at HKD 15.050, up 0.74%. The ETF opened at HKD 14.900, with the latest net asset value (NAV) at HKD 14.978, a discount of 0.26%, a 52-week high of HKD 16.950, a 52-week low of HKD 12.710, a turnover of approximately HKD 7,482, and assets under management of approximately HKD 25.46 million.
E Fund (HK) Solactive Biopharma Select Index ETF (03186.HK) tracks the Solactive Biopharma Select Index (Net Total Return), focusing on frontier sectors such as innovative drugs, CXO, and biotechnology.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- HK shares ETFs Daily Report : Biotech & High-Dividend ETFs Edge Higher Modestly, Leveraged ChiNext, Korea and Taiwan ETFs Plunge - 20260902
- HK shares ETFs Daily Report: Gold Miners Extend Gains 5.7%! Blockchain and Korea Counterattack in Tandem, Biomedicine and MedTech Lead Declines - 20260821
- E Fund (HK) Solactive Biopharma Select Index ETF (03186.HK) Rises 6.00% to HKD 15.550
- E Fund (HK) Solactive Biopharma Select Index ETF (03186.HK) Rises 1.07% to HKD 15.100
- CSOP Huatai-Pinebridge CSI Photovoltaic Industry ETF (03134.HK) Rises 0.46% to HKD 4.820